Bio-Europe, Nov 11-13 in Hamburg

Oct 15, 2019

Gerben C.M. Zondag, CEO of Immunetune, will attend the BIO-Europe meeting in Hamburg, November 11-13, 2019.

 

Feel free to request a meeting if you’d like to hear more about possible partnering of investment opportunities.

Immunetune joins the fight against Sars-CoV-2

Immunetune joins the fight against Sars-CoV-2

Within a newly established consortium, Immunetune will develop enhanced DNA vaccines against SARS-CoV-2 and other human coronaviruses. The vaccine is built on the combination of two strong synthetic vaccine platforms and the inclusion of conserved T and B cell...

read more